We are live on ! Find out more
DCP

Distillate Capital Partners Portfolio holdings

AUM $1.9B
1-Year Est. Return 2.22%
This Fund
S&P 500
This Quarter Est. Return
+1.25%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
AUM
$1.94B
AUM Growth
+$13.5M
Cap. Flow
+$2.74M
Cap. Flow %
0.14%
Top 10 Hldgs %
20.46%
Holding
139
New
20
Increased
25
Reduced
71
Closed
23

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$31.6M
2
VST icon
Vistra
VST
+$23.7M
3
DHI icon
D.R. Horton
DHI
+$20.2M
4
TEL icon
TE Connectivity
TEL
+$19.6M
5
GPN icon
Global Payments
GPN
+$18.7M

Top Sells

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$25.2M
2
ELV icon
Elevance Health
ELV
+$24.7M
3
HCA icon
HCA Healthcare
HCA
+$23.1M
4
FISV
Fiserv Inc
FISV
+$22.7M
5
JNJ icon
Johnson & Johnson
JNJ
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 25.29%
2 Healthcare 23.48%
3 Industrials 15.5%
4 Consumer Discretionary 10.53%
5 Consumer Staples 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
1
AbbVie
ABBV
$454B
$50.2M 2.58%
219,688
-6,633
-3% -$1.51M
MRK icon
2
Merck
MRK
$323B
$46.8M 2.41%
444,426
-113,557
-20% -$10.7M
TMUS icon
3
T-Mobile US
TMUS
$190B
$46.7M 2.41%
230,220
+43,578
+23% +$9.24M
PG icon
4
Procter & Gamble
PG
$346B
$38.9M 2%
271,371
+15,924
+6% +$2.35M
JNJ icon
5
Johnson & Johnson
JNJ
$641B
$38.4M 1.98%
185,350
-94,567
-34% -$18.7M
CSCO icon
6
Cisco
CSCO
$452B
$36.9M 1.9%
481,090
-99,688
-17% -$7.4M
CRM icon
7
Salesforce
CRM
$142B
$36.6M 1.88%
138,058
-2,903
-2% -$721K
CMCSA icon
8
Comcast
CMCSA
$80.9B
$36.1M 1.86%
1,207,612
-23,344
-2% -$666K
BMY icon
9
Bristol-Myers Squibb
BMY
$128B
$35.1M 1.81%
+657,723
New +$31.6M
QCOM icon
10
Qualcomm
QCOM
$179B
$31.7M 1.63%
185,313
-2,801
-1% -$480K
ACN icon
11
Accenture
ACN
$94.3B
$30.8M 1.58%
114,650
-2,023
-2% -$514K
UBER icon
12
Uber
UBER
$139B
$29.8M 1.53%
364,220
+111,416
+44% +$10M
CI icon
13
Cigna
CI
$77B
$29.4M 1.51%
106,700
-1,976
-2% -$554K
AMGN icon
14
Amgen
AMGN
$203B
$28.7M 1.48%
87,695
-2,339
-3% -$742K
BKNG icon
15
Booking.com
BKNG
$145B
$27M 1.39%
126,225
-1,925
-2% -$396K
ADBE icon
16
Adobe
ADBE
$94.5B
$26.5M 1.37%
75,758
-1,503
-2% -$511K
MCK icon
17
McKesson
MCK
$99.5B
$25M 1.29%
30,517
-624
-2% -$509K
LMT icon
18
Lockheed Martin
LMT
$134B
$24.1M 1.24%
49,829
-844
-2% -$404K
MO icon
19
Altria Group
MO
$122B
$23.8M 1.23%
413,178
-394
-0.1% -$23.8K
MPC icon
20
Marathon Petroleum
MPC
$91.2B
$23.8M 1.22%
146,262
+41,531
+40% +$7.76M
UNP icon
21
Union Pacific
UNP
$178B
$23.8M 1.22%
102,678
-1,271
-1% -$290K
FDX icon
22
FedEx
FDX
$73.5B
$23.3M 1.2%
80,490
-1,034
-1% -$272K
PYPL icon
23
PayPal
PYPL
$49.5B
$23M 1.19%
394,589
+78,857
+25% +$5.12M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$69.9B
$21.9M 1.13%
28,378
-8,734
-24% -$5.93M
VST icon
25
Vistra
VST
$53B
$21M 1.08%
+130,199
New +$23.7M

Similar funds

Distillate Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Distillate Capital Partners held 139 positions worth $1.94B, up 0.7% from $1.93B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Distillate Capital Partners's Q4 2025 filing shows 20 new, 25 increased, 71 reduced and 23 closed positions. Its largest new stake was Bristol-Myers Squibb: 657,723 shares worth $35.1M. The largest sale was Lowe's Companies, an estimated $25.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Distillate Capital Partners's largest Q4 2025 buy was Bristol-Myers Squibb: 657,723 shares worth $35.1M.
  • Distillate Capital Partners added most to Uber in Q4 2025, an estimated $10M increase.
  • Distillate Capital Partners's biggest Q4 2025 reduction was Johnson & Johnson, cutting an estimated $18.7M.
  • Distillate Capital Partners fully exited Lowe's Companies in Q4 2025, selling an estimated $25.2M.
  • Distillate Capital Partners's ten largest holdings make up 20% of its $1.94B portfolio in Q4 2025.
  • Distillate Capital Partners opened 20 new positions and closed 23 in Q4 2025.
  • Distillate Capital Partners's portfolio value rose 0.7% quarter-over-quarter to $1.94B.

Based on Distillate Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.